Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer

ABSTRACT: A randomized, phase II study comparing the sequences of regorafenib and trifluridine/tipiracil, after failure of standard therapies in patients with metastatic colorectal cancer

DISEASE(S): Metastatic Colorectal Cancer,The Study Population Will Consist Of Male And Female Patients Aged ≥ 18 Years Old With Metastatic Colorectal Cancer After Failure Of Fluoropyrimidine-, Irinotecan-, And Oxaliplatin-based Chemotherapies, As Well As Egfr And Vegf Inhibitors In Patients Eligible For These Treatments.,Colorectal Neoplasms,Adenocarcinoma Of Colon Metastatic

PROVIDER: 2344028 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR